The Mark Hughes Foundation funded Brain Cancer Biobank which forms part of the Hunter Cancer Biobank (HCB) and works in collaboration with Brain Cancer Biobanking Australia currently have 4 research projects utilising samples generous provided by patients.

Currently four research projects are working with the samples from the biobank:

  1. Dr. James Lynam study on predicting clinical toxicity in GBM patients.
  2. An observational clinical trial. EphA2 as a circulating biomarker for GBM progression.
  3. A Quality Assurance Project: Glioblastoma circulating tumour cell isolation and detection
  4. Whole exome sequencing of DNA to reveal the genetics of brain tumour development

Clinical Trials Access for Patients

View all News

Minister Hunt welcomes the Mark Hughes Foundation

Share this page